Símbolo de cotizaciónTBXU
Clase de activoEquity
Gestor del fondoDirexion
DomicilioUS
Ratio de gastos0.98%
Fundada en2025-10-01
Índice de referenciaNYSE Biotechnology Top 5 Equal Weight Index - Benchmark TR Gross
TBXU was created on 2025-10-01 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry.